JPRN-UMIN000047418已完成未知
The clinical impact of immunoglobulin replacement therapy on severe bacterial infection for patients with hypogammaglobulinemia secondary to hematologic malignancies: A Japanese claims database study - A database study on immunoglobulin replacement therapy in patients with secondary hypogammaglobulinemia
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 125
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 16years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Diagnosed with immunodeficiency (primary immunodeficiency [PID; disease code: 2793012] or human immunodeficiency virus [HIV; ICD-10 code: B20x-B24x]) during the study period. (2) Diagnosed with any other diseases* for which immunoglobulins can be used according to regulations in Japan (ICD-10 code: D693, G360, G610, G618, G700, H46x, L10x, L12x, L511, L512, M301, M303, M33x) during the study period. (3) Have a record of immunoglobulin treatment before the initial diagnosis of hypogammaglobulinemia.
研究者
相似试验
尚未招募
不适用
Efficacy of intravenous immunoglobulin replacement therapy for hypogammaglobulinemia in severe infectionssevere infectious diseasesJPRN-UMIN000032802Sapporo Medical University300
尚未招募
Unknown
Intravenous Immunoglobulin replacement therapy for persistent COVID-19 in patients with B-cell impairment: a multicenter randomized controlled trialCertain infectious and parasitic diseasesKCT0009239Samsung Medical Center58
进行中（未招募）
1 期
Efficacy of immunoglobulins in pediatric early-onset corticosteroid nephrotic syndromeChildhood-Onset steroid-dependent nephrotic syndromeMedDRA version: 20.1Level: PTClassification code 10029164Term: Nephrotic syndromeSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2017-000826-36-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)90
招募中
2 期
IVIG for Infection Prevention After CAR-T-Cell TherapyNCT05952804Fred Hutchinson Cancer Center150
尚未招募
不适用
comparison of immunoglobulin Y and probiotics in reduction of bacterial loadCTRI/2020/06/026249DR SAKSHI JAI